Mounjaro: Who Loses the Most Weight?

#Mounjaro #Tirzepatide #GLP1 #WeightLoss #obesitymedicine

Why do two people on the same Mounjaro dose get completely different results? In this video, I break down a study of more than 3,000 people with type 2 diabetes from the SURPASS 1–4 trials. It looked at who is most likely to lose 15% or more of their body weight on tirzepatide (Mounjaro / Zepbound), and why.

You'll learn the 7 factors that predicted the biggest weight loss. Several of them are things you can change, sometimes before your first injection. I also cover what newer research says about Ozempic and Wegovy, why real-world results are lower than trial results, and the 6-month check-in that tells you whether you're on track.

📩 FREE GLP-1 Diet Cookbook + Weekly Newsletter

Get weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.

https://www.drmohammedpaika.com/newsletter

🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime Access

Comprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.

https://www.drmohammedpaika.com

TIMESTAMPS

0:00 Same drug, very different results

1:15 Mounjaro vs Zepbound vs Ozempic explained